|
|
 Previous Article | Table of Contents | Next Article 
Blood, 15 March 2001, Vol. 97, No. 6, pp. 1742-1749
IMMUNOBIOLOGY
Selective inhibition of interleukin-4 gene expression in human T
cells by aspirin
Antonella Cianferoni,
John
T. Schroeder,
Jean Kim,
John W. Schmidt,
Lawrence M. Lichtenstein,
Steve N. Georas, and
Vincenzo Casolaro
From the Departments of Medicine and Otolaryngology,
The Johns Hopkins School of Medicine, Baltimore, MD.
Previous studies indicated that aspirin (acetylsalicylic acid
[ASA]) can have profound immunomodulatory effects by regulating cytokine gene expression in several types of cells. This study is the
first in which concentrations of ASA in the therapeutic range were
found to significantly reduce interleukin (IL)-4 secretion and RNA
expression in freshly isolated and mitogen-primed human CD4+ T cells. In contrast, ASA did not affect IL-13,
interferon- , and IL-2 expression. ASA inhibited IL-4, but not IL-2,
promoter-driven chloramphenicol acetyltransferase expression in
transiently transfected Jurkat T cells. The structurally unrelated
nonsteroidal anti-inflammatory drugs indomethacin and flurbiprofen
did not affect cytokine gene expression in T cells, whereas the weak
cyclo-oxygenase inhibitor salicylic acid was at least as effective as
ASA in inhibiting IL-4 expression and promoter activity. The inhibitory
effect of ASA on IL-4 transcription was not mediated by decreased
nuclear expression of the known salicylate target nuclear factor
(NF)- B and was accompanied by reduced binding of an inducible
factor to an IL-4 promoter region upstream of, but not overlapping, the NF of activated T cells- and NF-B-binding P1 element. It is
concluded that anti-inflammatory salicylates, by means of a previously
unrecognized mechanism of action, can influence the nature of adaptive
immune responses by selectively inhibiting the expression of IL-4, a critical effector of these responses, in CD4+ T cells.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. R. King, A. S. Ismail, L. S. Davis, and D. R. Karp
Oxidative stress promotes polarization of human T cell differentiation toward a T helper 2 phenotype.
J. Immunol.,
March 1, 2006;
176(5):
2765 - 2772.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. K. Wu, J.-Y. Liou, and K. Cieslik
Transcriptional Control of COX-2 via C/EBP{beta}
Arterioscler Thromb Vasc Biol,
April 1, 2005;
25(4):
679 - 685.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Nakagawa, K. Kushiya, I. Taneike, K. Imanishi, T. Uchiyama, and T. Yamamoto
Specific Inhibitory Action of Anisodamine against a Staphylococcal Superantigenic Toxin, Toxic Shock Syndrome Toxin 1 (TSST-1), Leading to Down-Regulation of Cytokine Production and Blocking of TSST-1 Toxicity in Mice
Clin. Vaccine Immunol.,
March 1, 2005;
12(3):
399 - 408.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S Durand, M Tartas, P Bouye, A Koitka, J. L Saumet, and P Abraham
Prostaglandins participate in the late phase of the vascular response to acetylcholine iontophoresis in humans
J. Physiol.,
December 15, 2004;
561(3):
811 - 819.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Aceves, A. Duenas, C. Gomez, E. San Vicente, M. S. Crespo, and C. Garcia-Rodriguez
A New Pharmacological Effect of Salicylates: Inhibition of NFAT-Dependent Transcription
J. Immunol.,
November 1, 2004;
173(9):
5721 - 5729.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Durand, B. Fromy, M. Tartas, A. Jardel, J. L. Saumet, and P. Abraham
Prolonged aspirin inhibition of anodal vasodilation is not due to the trafficking delay of neural mediators
Am J Physiol Regulatory Integrative Comp Physiol,
July 1, 2003;
285(1):
R155 - R161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Cyrus, S. Sung, L. Zhao, C. D. Funk, S. Tang, and D. Pratico
Effect of Low-Dose Aspirin on Vascular Inflammation, Plaque Stability, and Atherogenesis in Low-Density Lipoprotein Receptor-Deficient Mice
Circulation,
September 3, 2002;
106(10):
1282 - 1287.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Nazarenko, B. Lowe, M. Darfler, P. Ikonomi, D. Schuster, and A. Rashtchian
Multiplex quantitative PCR using self-quenched primers labeled with a single fluorophore
Nucleic Acids Res.,
May 1, 2002;
30(9):
e37 - e37.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Perez-G., M. Melo, A. D. Keegan, and J. Zamorano
Aspirin and Salicylates Inhibit the IL-4- and IL-13-Induced Activation of STAT6
J. Immunol.,
February 1, 2002;
168(3):
1428 - 1434.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. TEGEDER, J. PFEILSCHIFTER, and G. GEISSLINGER
Cyclooxygenase-independent actions of cyclooxygenase inhibitors
FASEB J,
October 1, 2001;
15(12):
2057 - 2072.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
